Literature DB >> 3179887

The ethics of physician-pharmaceutical company relationships.

W G Thompson1.   

Abstract

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh：

Year:  1988        PMID： 3179887      PMCID： PMC1268336     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  The future of new oral antibiotics including the quinolones.

Authors:  M G Bergeron
Journal:  CMAJ       Date:  1988-01-01       Impact factor: 8.262

2.  Erythromycin-sulfisoxazole vs amoxicillin in the treatment of acute otitis media in children. A double-blind, multiple-dose comparative study.

Authors:  W J Rodriguez; R H Schwartz; T Sait; W N Khan; O P Chhabra; M J Chang; S Reddy; L A Marks; A J Gold
Journal:  Am J Dis Child       Date:  1985-08

3.  Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.

Authors:  M G Bergeron; G Ahronheim; J E Richard; K Riding; C Cron; D Bryer; N Macdonald; M Bouchard; J Young; E E Dempsey
Journal:  Pediatr Infect Dis J       Date:  1987-07       Impact factor: 2.129
  3 in total
  2 in total

1.  Snake oil and Caesar salad: the ethics of physician and pharmaceutical relationships.

Authors:  R F Woollard
Journal:  CMAJ       Date:  1991-10-15       Impact factor: 8.262

Review 2.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.